This inventor holds 1 USPTO granted patent. Top assignee: Consejo Superior De Investigaciones Cientificas. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Angel Ramirez Ortiz: Innovator in Immunosuppressive Agents
Introduction
Angel Ramirez Ortiz is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of medicinal drugs, particularly in the development of immunosuppressive agents. His work focuses on innovative solutions that address critical health challenges.
Latest Patents
Angel Ramirez Ortiz holds a patent for an immunosuppressor based on the blockage of TCR-Nck interaction. The patent describes a compound of structural formula (I) and its derivatives for use as medicinal drugs. These compounds are primarily designed to act as immunosuppressive agents, utilizing a mechanism of action that blocks the TCR-Nck interaction. This innovative approach has the potential to advance therapeutic options in immunology.
Career Highlights
Angel Ramirez Ortiz is affiliated with the Consejo Superior de Investigaciones Científicas, a prominent research institution in Spain. His role at this institution has allowed him to engage in cutting-edge research and development in the field of immunology. His dedication to advancing medical science is evident through his innovative work and patent achievements.
Collaborations
Angel Ramirez Ortiz has collaborated with esteemed colleagues, including Balbino Jose Alarcon Sanchez and Aldo Jorge Borroto Revuelta. These collaborations have fostered a productive research environment, contributing to the advancement of their shared goals in medical innovation.
Conclusion
Angel Ramirez Ortiz is a distinguished inventor whose work in immunosuppressive agents showcases his commitment to improving healthcare solutions. His patent and collaborations reflect his significant impact on the field of medicinal drugs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile